Showing results (1051-1060 of 1,205) with videos related to

Sort By:
Pageof 121
Annals of Surgical Oncology|July 27, 2022
Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion ChemotherapyRaja R Narayan, Jashodeep Datta, Debra A Goldman, et al.
Clinical and Translational Science|April 25, 2025
Ethnic Sensitivity Assessment of Mosunetuzumab Pharmacokinetics and Pharmacodynamics in Chinese Patients With Relapsed or Refractory Follicular LymphomaJunyi Li, Michael Z Liao, Justin Wilkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2018
Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor-Positive Advanced Breast CancerMaura N Dickler, Cristina Saura, Donald A Richards, et al.
Journal of Surgical Oncology|January 23, 2022
Association of genomic profiles and survival in early onset and screening-age colorectal cancer patients with liver metastases resected over 15 yearsRaja R Narayan, Victoria G Aveson, Joanne F Chou, et al.
Annals of Surgery|January 26, 2022
Grading Pancreatic Neuroendocrine Tumors Via Endoscopic Ultrasound-guided Fine Needle Aspiration: A Multi-institutional StudyAmmar A Javed, Alessandra Pulvirenti, Samrah Razi, et al.
Surgery|August 5, 2022
Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapyGuoliang Qiao, Crisanta H Ilagan, Carlos Fernandez-Del Castillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer CareSaptarshi Chakraborty, Brett L Ecker, Ken Seier, et al.
Blood Advances|February 5, 2025
Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 studyJason Westin, Tycel J Phillips, Amitkumar Mehta, et al.
Annals of Surgical Oncology|July 23, 2024
Has Management of Intrahepatic Cholangiocarcinoma Evolved with the Evidence? Trends and Practice Patterns from the National Cancer DatabaseLauren E Schleimer, Hannah L Kalvin, Ryan J Ellis, et al.
Journal of the National Cancer Institute|March 20, 2026
Restaging after neoadjuvant FOLFIRINOX for localized pancreatic cancer: a clinical calculator from the Trans-Atlantic Pancreatic Surgery consortiumEsther N Dekker, David van Klaveren, Eva M M Verkolf, et al.
Pageof 121